Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. Established in 1983 by Dilip Shanghvi, Sun Pharma has grown to become the largest chronic prescription provider in India and the fifth-largest specialty generic pharmaceutical company globally.

Sun Pharma specializes in developing, manufacturing, and marketing a wide range of branded and generic formulations as well as active pharmaceutical ingredients (APIs). The company's product portfolio covers various therapeutic areas including cardiology, psychiatry, neurology, gastroenterology, diabetology, oncology, orthopedics, urology, dermatology, gynecology.

One of its notable products includes Tildrakizumab for treating moderate-to-severe plaque psoriasis. In terms of innovation and technology usage, Sun Pharma has been at the forefront with investments in research & development to develop novel drug delivery systems such as sprays and inhalers that offer improved patient convenience and compliance.

The company stands out from its competitors due to its strong global presence through strategic collaborations and partnerships. It has established itself as a reliable supplier by adhering to international quality standards while maintaining cost-effectiveness. Sun Pharma also operates several manufacturing facilities across the globe which comply with stringent regulatory norms set by major international health authorities like USFDA (United States Food & Drug Administration), MHRA (Medicines & Healthcare Products Regulatory Agency) UK among others. In addition to their innovative products and extensive reach worldwide, the firm's commitment towards sustainability practices sets them apart from their peers. They focus on reducing environmental impact through initiatives like waste minimization,renewable energy utilization,and water conservation efforts within their operations.Their dedication towards corporate social responsibility can be seen through various healthcare programs aimed at improving access to medicines for underprivileged communities along with education initiatives. Overall,Sun Pharmaceutical Industries Limited continues to expand its footprint while upholding high ethical standards,solidifying its position as one of the leading players in the global pharmaceutical industry.